Advertisement

Loading...

ETFMG Treatments, Testing and Advancements ETF

GERM•AMEX
Financial Services
Asset Management
$19.16
$-0.06(-0.29%)
U.S. Market is Open • 14:13

ETFMG Treatments, Testing and Advancements ETF (GERM) Stock Overview

Explore ETFMG Treatments, Testing and Advancements ETF’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap9.6M
P/E RatioN/A
EPS (TTM)$2.57
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$11.92

GERM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ETFMG Treatments, Testing and Advancements ETF (GERM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $11.92.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 9.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-0.01%
3-Month Change
3.67%
6-Month Change
7.21%
Year-to-Date (YTD) Change
-4.59%
1-Year Change
9.54%
3-Year Change
-50.52%
5-Year Change
-23.83%
All-Time (Max) Change
-23.83%

Contact Information

NaN
NaN
NaN, NaN, DE, NaN

Company Facts

IPO DateJun 18, 2020
CountryUS

Frequently Asked Questions